Generic medicines: Greek physicians' perceptions and prescribing practices

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 5, 2009, Pages 547-554

  Tsiantou, V ^a   Zavras, D ^a,b   Kousoulakou, H ^c   Geitona, M ^b   Kyriopoulos, J ^a  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c Foundation for Economic and Industrial Research   (Greece)

Author keywords

Drug cost; Drug prescribing; Generics; Pharmaceutical policy; Physicians' views

Indexed keywords

GENERIC DRUG;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG QUALITY; GREECE; HEALTH INSURANCE; MEDICAL DECISION MAKING; PHYSICIAN ATTITUDE; PRESCRIPTION; STRUCTURED QUESTIONNAIRE;

ADULT; AGED; DRUG COSTS; DRUG PRESCRIPTIONS; DRUGS, GENERIC; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS;

EID: 70049115530     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01037.x     Document Type: Article

References (28)

1. Garattini L, Tediosi F (2000) Comparative analysis of generic markets in five European countries. Health Policy, 51, 149 162.
2. Perry G (2006) The European pharmaceutical market in review: 2006 and beyond. Journal of Generics Medicines, 4, 4 14.
3. King DR, Kanavos P (2002) Encouraging the use of generic medicines: implications for transition economies. Croatian Medical Journal, 43, 462 469.
4. Campbell M, Smith M, Beaney A (1995) The pros and cons of generic medicines. Pharmacoeconomics, 8, 362 364.
5. Kessler D, Rose JL, Temple RJ, Shapiro R, Griffin JP (1994) Therapeutic-class wars: drug promotion in a competitive marketplace. New England Journal of Medicine, 331, 1350 1354.
6. Ess SM, Schneeweiss S, Szucs TD (2003) European healthcare policies for controlling drug expenditure. Pharmacoeconomics, 21, 89 103.
7. Mossialos E, Mrazek M (2002) Entrepreneurial behaviour in pharmaceutical markets and the effects of regulation. In : Saltmant R, Busse R, Mossialos E, eds. Regulating entrepreneurial behaviour in European health care systems. Buckingham : Open University Press, 61 86.
8. Simoens S, De Coster S (2006) Sustaining generic medicines in market in Europe. Leuven : Research Centre for Pharmaceutical Care and Pharmacoeconomics, Katholeke Universiteit.
9. Kanavos P, Taylor D (2007) Pharmacy discounts on generic medicines in France: is there room for further efficiency savings? Current Medical Research and Opinion, 23, 2467 2476.
10. Paraponaris A, Verger P, Desquins B et al. (2004) Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names Health Policy, 70, 23 32.
11. Kanavos P (2007) Do generics offer significant savings to the UK National Health Service? Current Medical Research and Opinion, 23, 105 116.
12. Kousoulakou H, Vitsou E (2008) Pharmaceutical market in Greece. Athens, Greece : Foundation for Economic and Industrial Research (IOBE) (in Greek).
13. Mossialos E, Allin S, Davaki K (2005) Analysing the Greek health system: a tale of fragmentation and inertia. Health Economics, 14, 151 168.
14. Contiades X, Golna C, Souliotis K (2007) Pharmaceutical regulation in Greece at the crossroad of change: economic, political and constitutional considerations for a regulatory paradigm. Health Policy, 82, 116 129.
15. European Generic Medicines Association (EGA) (2007) The role of generic medicines in Europe, facts and figures from EGA on generics market shares and the healthcare gap. Available at: http://www.egagenerics.com (accessed 25 January 2008).
16. European Federation of Pharmaceutical Industries and Associations EFPIA (2008) The pharmaceutical industry in figures, key data, annual updates. Available at: http://www.efpia.eu/Content/Default.asp?PageID=559&DocID=4883 (accessed 25 January 2008).
17. Geitona M, Zavras D, Hatzikou M, Kyriopoulos J (2006) The generics market in Greece: the pharmaceutical industry beliefs. Health Policy, 79, 35 48.
18. Hosmer DW, Lemeshow S (2000) Applied logistic regression. Hoboken, NJ : John Wiley & Sons.
19. Heikkila R, Mantyselka P, Hartikainen- Herranen K, Ahonen R (2007) Customers' and physicians' opinions of the experiences with generic substitution during the first year in Finland. Health Policy, 82, 366 374.
20. Kersnik J, Peklar J (2006) Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. Journal of Clinical Pharmacy and Θherapeutics, 31, 577 583.
21. Hassali MA, Kong D, Stewart K (2006) Generic medicines: Perceptions of general practitioners in Melbourne, Australia. Journal of Generic Medicines, 3, 214 225.
22. Barrett LL (2005) Physicians' attitudes and practices regarding generic drugs. Available at: http://assets.aarp.org/rgcenter/health/phys-generic.pdf (accessed 14 March 2008).
23. Bower AD, Burkett GL (1987) Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes and practices. Journal of Family Practice, 24, 612 616.
24. Banahan BF III., Kolassa EM (1997) A physician survey on generic drugs and substitution of critical dose medications. Archives of Internal Medicine, 157, 2080 2088.
25. Reichert S, Simon T, Halm E (2000) Physicians' attitudes about prescribing and knowledge of the costs of common medications. Archives of Internal Medicine, 160, 2799 2803.
26. Alexander G, Casalino L, Meltzer D (2005) Physician strategies to reduce patients' out of pocket prescription costs. Archives of Internal Medicine, 165, 633 636.
27. Greek Medical Association (2006). Available at: http://www.pis.gr (accessed on 2 March 2007).
28. National Statistical Service of Greece (NSSG) (2006). Concise statistical yearbook of Greece. Available at: http://www.statistics.gr/ (accessed 2 March 2007).